The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
Development and Validation of a Sonographic Enthesitis Instrument in Psoriatic Arthritis: The GRAPPA Diagnostic Ultrasound Enthesitis Tool (DUET) Project |
J Rheumatol Suppl. 2020 Jun;96:50-52. doi: 10.3899/jrheum.200128. |
| 2 | |
JAK inhibitors, Psoriatic Arthritis, and Axial Spondyloarthritis: a Critical Review of Clinical Trials |
Expert Rev Clin Immunol. 2021 May 4. doi: 10.1080/1744666X.2021.1925541.Online ahead of print. |
| 3 | |
Updated therapies for the management of Psoriatic Arthritis |
Clin Immunol. 2020 Nov;220:108536. doi: 10.1016/j.clim.2020.108536.Epub 2020 Jul 16. Atrin Toussi 1, Natalia Maverakis 2, Stephanie T Le 3, Soumajyoti Sarkar 4, Smriti K Raychaudhuri 5, Siba P Raychaudhuri 6 |
| 4 | |
Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis |
J Rheumatol. 2021 Apr 15;jrheum.210175. doi: 10.3899/jrheum.210175. Online ahead of print. Ying Ying Leung 1, William Tillett 1, Pil Hojgaard 1, Ana-Maria Orbai 1, Richard Holland 1, Ashish J Mathew 1, Niti Goel 1, Jeffrey Chau 1, Chris Lindsay 1, Alexis Ogdie 1, Laura C Coates 1, Robin Christensen 1, Philip Mease 1, Vibeke Strand 1, Dafna D Gladman 1 |
| 5 | |
Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes |
Semin Arthritis Rheum. 2021 Apr 15;51(3):530-538.doi: 10.1016/j.semarthrit.2021.04.003. Online ahead of print. Yvette Meissner 1, Tatjana Rudi 2, Rebecca Fischer-Betz 3, Anja Strangfeld 2 |
| 6 | |
The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data |
Br J Dermatol. 2021 Apr 8. doi: 10.1111/bjd.20136. Online ahead of print. M Lebwohl 1, A Deodhar 2, C E M Griffiths 3, M A Menter 4, D Poddubnyy 5, W Bao 6, V Jehl 7, K Marfo 7, P Primatesta 7, A Shete 7, V Trivedi 6, P J Mease 8 |
| 7 | |
GRAPPA Treatment Recommendations: Updates and Methods |
J Rheumatol Suppl. 2020 Jun;96:41-45. doi: 10.3899/jrheum.200126. Arthur Kavanaugh 1 2, Laura C Coates 3 4, Danielle A van der Windt 3 4, Nadia Corp 3 4, Enrique R Soriano 3 4 |
| 8 | |
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study |
Rheumatol Ther. 2020 Sep;7(3):553-580.doi: 10.1007/s40744-020-00209-4. Epub 2020 Jun 6. Peter Nash 1, Laura C Coates 2, Alan J Kivitz 3, Philip J Mease 4, Dafna D Gladman 5, José A Covarrubias-Cobos 6, Oliver FitzGerald 7, Dona Fleishaker 8, Cunshan Wang 8, Joseph Wu 8, Ming-Ann Hsu 8, Sujatha Menon 8, Lara Fallon 9, Ana Belén Romero 10, Keith S Kanik 8 |
| 9 | |
Methotrexate in Psoriasis and Psoriatic Arthritis |
J Rheumatol Suppl. 2020 Jun;96:31-35. doi: 10.3899/jrheum.200124. Laura C Coates 1 2 3, Joseph F Merola 4 5 6, Suzanne M Grieb 4 5 6, Philip J Mease 4 5 6, Kristina Callis Duffin 4 5 6 |
| 10 | |
Resolution of Enthesitis by Guselkumab and Relationships to Disease Burden: 1-Year Results of Two Phase-3 Psoriatic Arthritis Studies |
Rheumatology (Oxford). 2021 Apr 6;keab285. doi: 10.1093/rheumatology/keab285.Online ahead of print. Dennis McGonagle 1, Iain B McInnes 2, Atul Deodhar 3, Georg Schett 4, May Shawi 5, Shelly Kafka 6, Chetan S Karyekar 5, Alexa P Kollmeier 7, Elizabeth C Hsia 7 8, Xie L Xu 7, Shihong Sheng 9, Prasheen Agarwal 9, Bei Zhou 9, Christopher T Ritchlin 10, Proton Rahman 11, Philip J Mease 12 |
| 11 | |
Current treatments and recommendations |
Best Pract Res Clin Rheumatol. 2021 Apr 3;101680. doi: 10.1016/j.berh.2021.101680.Online ahead of print. |
| 12 | |
Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry |
J Rheumatol. 2020 Jun 1;jrheum.191117. doi: 10.3899/jrheum.191117. Online ahead of print. Philip J Mease 1, Mei Liu 1, Sabrina Rebello 1, Winnie Hua 1, Robert R McLean 1, Peter Hur 1, Alexis Ogdie 1 |
| 13 | |
Psoriatic arthritis and COVID-19 pandemic: Consequences in medical treatment? |
Dermatol Ther. 2020 Sep;33(5):e13743. doi: 10.1111/dth.13743. Epub 2020 Jun 30. Uwe Wollina 1, Massimo Fioranelli 2, Mohamad Goldust 3 4 5, Torello Lotti 6 |
| 14 | |
Not your average joint: Towards precision medicine in psoriatic arthritis |
Clin Immunol. 2020 Aug;217:108470. doi: 10.1016/j.clim.2020.108470.Epub 2020 May 28. |
| 15 | |
Evaluation of a Genetic Risk Score for Diagnosis of Psoriatic Arthritis |
J Psoriasis Psoriatic Arthritis. 2020 Apr;5(2):61-67. doi: 10.1177/2475530320910814.Epub 2020 Mar 4. Mary Patricia Smith 1, Karen Ly 1, Quinn Thibodeaux 1, Kristen Beck 1, Eric Yang 1 2, Isabelle Sanchez 1 3, Joanne Nititham 1, Tina Bhutani 1, Wilson Liao 1 |
| 16 | |
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis |
PLoS One. 2020 May 27;15(5):e0233781. doi: 10.1371/journal.pone.0233781.eCollection 2020. Johan Burisch 1, Wolfgang Eigner 2, Stefan Schreiber 3, Daniel Aletaha 4, Wolfgang Weninger 5, Michael Trauner 2, Walter Reinisch 2, Neeraj Narula 6 |
| 17 | |
Costs and Health Outcomes Associated with Tofacitinib Treatment for Active Psoriatic Arthritis in the United States |
J Manag Care Spec Pharm. 2020 Aug;26(8):1027-1038. doi: 10.18553/jmcp.2020.19319.Epub 2020 Apr 20. George Bungey 1, Stacey Chang-Douglass 1, Ming-Ann Hsu 2, Joseph C Cappelleri 2, Pamela Young 3, John Woolcott 3 |
| 18 | |
Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies |
Curr Med Res Opin. 2020 Jul;36(7):1245-1252. doi: 10.1080/03007995.2020.1754186.Epub 2020 Apr 23. Jessica A Walsh 1, Qian Cai 2, Iris Lin 3, Timothy Fitzgerald 3, Christopher D Pericone 2, Soumya D Chakravarty 3 4 |
| 19 | |
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases |
J Rheumatol. 2021 Jan 1;48(1):48-57. doi: 10.3899/jrheum.190815. Epub 2020 Apr 1. Matthew L Thomas 1, Gavin Shaddick 2, Rachel Charlton 3, Charlotte Cavill 4, Richard Holland 4, Florenzo Iannone 5, Giovanni Lapadula 5, Simona Lopriore 5, Jakub Závada 6, Michal Uher 7, Karel Pavelka 6, Lenka Szczuková 7, Prodromos Sidiropoulos 8, Irini Flouri 8, Alexandros Drosos 9, Burkhard Möller 10, Michael J Nissen 11, Rüdiger B Müller 12, Almut Scherer 13, Neil McHugh 14, Alison Nightingale 15 |
| 20 | |
Psoriatic arthritis in childhood: A commentary on the controversy |
Clin Immunol. 2020 May;214:108396. doi: 10.1016/j.clim.2020.108396.Epub 2020 Mar 27. |
| 21 | |
Challenges in the clinical diagnosis of psoriatic arthritis |
Clin Immunol. 2020 May;214:108390. doi: 10.1016/j.clim.2020.108390.Epub 2020 Mar 18. |
| 22 | |
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial |
Lancet. 2020 Apr 4;395(10230):1126-1136.doi: 10.1016/S0140-6736(20)30263-4. Epub 2020 Mar 13. Philip J Mease 1, Proton Rahman 2, Alice B Gottlieb 3, Alexa P Kollmeier 4, Elizabeth C Hsia 5, Xie L Xu 4, Shihong Sheng 6, Prasheen Agarwal 6, Bei Zhou 6, Yanli Zhuang 7, Désirée van der Heijde 8, Iain B McInnes 9, DISCOVER-2 Study Group |
| 23 | |
Complexities in Genetics of Psoriatic Arthritis |
Curr Rheumatol Rep. 2020 Mar 12;22(4):10. doi: 10.1007/s11926-020-0886-x. Sara Rahmati 1 2, Lam Tsoi 3, Darren O'Rielly 1, Vinod Chandran 1 2 4 5 6, Proton Rahman 7 |
| 24 | |
Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis |
Rheumatology (Oxford). 2020 Sep 1;59(9):2199-2206.doi: 10.1093/rheumatology/keaa062. Bradley Pittam 1, Sonal Gupta 1, Nicholas L Harrison 2, Selina Robertson 1, David M Hughes 3, Sizheng Steven Zhao 2 4 |
| 25 | |
The many faces of psoriatic arthritis: their genetic determinism |
Rheumatology (Oxford). 2020 Mar 1;59(Suppl 1):i4-i9.doi: 10.1093/rheumatology/kez325. |
| 26 | |
Ixekizumab for the treatment of psoriasis: up-to-date |
Expert Opin Biol Ther. 2020 Jun;20(6):549-557.doi: 10.1080/14712598.2020.1729736. Epub 2020 Mar 10. |
| 27 | |
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis |
Rheumatol Int. 2020 Apr;40(4):511-521. doi: 10.1007/s00296-020-04526-3.Epub 2020 Feb 12. Stephan Pflugbeil 1, Karin Böckl 2, Reinhold Pongratz 1, Marianne Leitner 3, Winfried Graninger 4, Astrid Ortner 5 |
| 28 | |
Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial |
Arthritis Res Ther. 2020 Mar 6;22(1):43. doi: 10.1186/s13075-020-2126-1. Philip Mease 1, M Elaine Husni 2, Shelly Kafka 3, Soumya D Chakravarty 3 4, Diane D Harrison 5, Kim Hung Lo 5, Stephen Xu 5, Elizabeth C Hsia 5 6, Arthur Kavanaugh 7 |
| 29 | |
Identifying and Characterizing Psoriasis and Psoriatic Arthritis Patients in Ontario Administrative Data: A Population-based Study From 1991 to 2015 |
J Rheumatol. 2020 Nov 1;47(11):1644-1651. doi: 10.3899/jrheum.190659. Epub 2020 Feb 15. Lihi Eder 1, Jessica Widdifield 2, Cheryl F Rosen 3, Raed Alhusayen 4, Stephanie Y Cheng 5, Jacqueline Young 5, Willemina Campbell 6, Sasha Bernatsky 7, Dafna D Gladman 8, Michael Paterson 9, Karen Tu 10 |
| 30 | |
Remission in psoriatic arthritis: Definition and predictors |
Semin Arthritis Rheum. 2020 Dec;50(6):1494-1499. doi: 10.1016/j.semarthrit.2020.01.012.Epub 2020 Feb 3. Samar Alharbi 1, Justine Y Ye 2, Ker-Ai Lee 3, Vinod Chandran 4, Richard J Cook 3, Dafna D Gladman 5 |